|

Understanding Acute Dietary Changes After GLP-1 Agonist Treatment: The GLaD Feasibility Study

RECRUITINGSponsored by Australian Catholic University
Actively Recruiting
SponsorAustralian Catholic University
Started2025-05-28
Est. completion2025-11-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07001553

Summary

An observational study of those who have been prescribed a GLP-1 agonist therapy (yet to commence), for either weight or diabetes management, and are willing to complete dietary records and questionnaires of behaviour and psychosocial health.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Aged 18+ years old
* Intending to commence a prescription for a GLP-1 agonist (may be dual agonist, i.e. Ozempic, Trulicity, Monjaro, or Saxenda) medication, with no use in the previous 6 months
* The primary reason for commencing the medication will be for diabetes or weight management
* Willing to participate in dietary recall and questionnaires

Exclusion Criteria:

* Aged under 18 years,
* used a GLP-1 agonist medication in the previous 6 months,
* unwilling or unable to provide dietary recalls
* non-English speaking.

Conditions3

DiabetesObesityType 2 Diabetes Mellitus (T2DM)

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.